Business Wire

Ant Group Announces Major Upgrades to Its 15-Million-MAU AI Health App AQ Amid Wider Push into Health Sector

Share

Ant Group today announced major upgrades to its AI health app AQ, with a new Chinese name “Ant A-Fu.” The character “Fu” conveys good wishes and well-being, reflecting the app’s goal to promote better health and quality of life.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215203213/en/

Ant Group’s AI health app AQ features three core capabilities: health Q&A, AI health companion, and integrated health services.

The upgraded version of AQ now features three core capabilities: health Q&A, AI health companion, and integrated health services.

Launched in June 2025, AQ has rapidly grown to 15 million monthly active users, making it China’s leading AI health management app. Positioned as an AI health companion service, AQ currently answers over 5 million health-related questions every day.

The announcement comes amid China’s ongoing demographic shift. According to projections from the National Health Commission, by around 2035, more than 400 million people, or over 30% of the population, will be aged 60 or above. This transformation is expected to significantly increase demand for health-related services, with AI-powered solutions playing a critical role in meeting those needs.

Building Healthier Habits with an AI Health Companion

The newly launched health companion feature is designed to help users develop and maintain healthy habits.

  • Users can log their health status directly in AQ. The app now also supports records integration from major smart device brands, such as Apple, Huawei, vivo, Yuwell, and Omron. With user consent, AQ can automatically sync daily health metrics—such as physical activity, heart rate, and sleep duration—from these devices.
    Beyond smart devices, users can also upload photos or images to record health information. AQ allows users to create health profiles for family members as well. Acting much like a family doctor, the app can track long-term health trends and help safeguard the well-being of the entire household.
  • Second, AQ introduces two new companion tools: health goal setting and smart reminders. Users can set goals related to exercise, diet, or lifestyle habits, while AQ functions like a personal trainer—creating tailored plans and sending daily reminders to help users stay on track.

More Personalized Health Q&A

With a deeper understanding of users’ health situations, AQ’s health Q&A function now delivers more accurate and personalized responses.

  • For users who find it difficult to clearly describe their symptoms, AQ’s “AI Clinic” tool simulates a real face-to-face consultation by proactively asking follow-up questions and offering visual prompts to help users express their concerns more precisely.
  • In addition to voice and text, AQ can also analyze images. Users can take photos of skin conditions, medical test reports, or medication packaging to receive clear explanations, with the capability of interpreting most medical reports.

AQ does not provide medical diagnoses or replace professional doctors. As Zhang Junjie, Vice President of Ant Group and Head of Health Business, explained: “AQ is designed to help users address common, everyday health questions and support healthy habit formation, meeting users’ daily health needs that don’t yet require a hospital visit.”

For cases requiring medical diagnosis, AQ connects users with a nationwide network of 300,000 doctors for online consultations. Users can also book in-person doctor appointments, purchase medication, and pay hospital bills using their basic medical insurance e-certificates directly through the app.

AQ has also partnered with over 500 leading physicians across China to launch their AI Doctor Agents on the platform, which provide health recommendations by learning from each doctor’s prior experience. Together, these agents have answered more than 27 million health-related inquiries.

By handling routine and everyday health questions, AQ allows doctors to focus more of their time on treating complex conditions. “AQ can serve as a powerful assistant to hospitals and physicians,” Zhang added. “By leveraging digital platforms and intelligent technology, we can enable one doctor to serve more patients, making high-quality health services more accessible and inclusive.”

About Ant Group

Ant Group is a global digital technology provider and the operator of Alipay, a leading internet services platform in China, connecting over one billion users to more than 10,000 types of consumer services from partners. Through innovative products and solutions powered by AI, blockchain and other technologies, Ant Group supports partners across industries to thrive through digital transformation in an ecosystem for inclusive and sustainable development. For more information, visit www.antgroup.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251215203213/en/

Contacts

Media Inquiries
Yinan Duan
duanyinan.dyn@antgroup.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Align Partners Sends Second Public Shareholder Letter to Coway, Urging Announcement of Revised Value-up Plan by January 30, 202615.12.2025 16:54:00 EET | Press release

Align Partners Capital Management Inc. (“Align Partners”), a shareholder of Coway Co., Ltd. (“Coway”) since 2023 holding more than 4% of the Company’s outstanding shares through funds it manages or advises, announced that it has sent a second public shareholder letter to Coway’s Board of Directors. The letter calls for measures to address the company’s chronic undervaluation and enhance shareholder value. Align Partners has requested that Coway announce a revised corporate Value-up Plan reflecting these proposals by January 30, 2026. In the letter, Align Partners assessed Coway’s February 2025 plan as insufficient to address Coway’s persistent undervaluation and urged the Board to incorporate seven measures: (1) clear mid-to-long-term valuation and ROE targets with execution plans; (2) clarified and strengthened target capital structure policy; (3) updated shareholder return policy reflecting both the target capital structure policy and new dividend income tax separation regime; (4) en

Marathon Asset Management Provides Junior Capital Financing to EXALTA Group15.12.2025 16:00:00 EET | Press release

Marathon Asset Management (“Marathon”), a leading global credit manager with more than $24 billion of assets under management, is pleased to announce the closing of a junior capital financing to EXALTA Group (“EXALTA” or the “Company”), a portfolio company of Montagu. Marathon led the financing that supported the formation of EXALTA through the strategic merger of three Montagu-owned companies including Intech, Resolve Surgical Technologies, and Tyber Medical. The transaction marks one of many successful transactions for Marathon’s European Credit business in the healthcare sector, where the firm has a knowledge-based advantage with a dedicated Healthcare Finance business and specialized medical advisory board providing sector insight to middle market companies. EXALTA is a global leader in orthopaedic contract design and manufacturing for spine, trauma, extremities, sports medicine and enabling technology providing comprehensive solutions to OEMs within the medical technology industry

Aurobay Technologies Expands Digital Transformation Partnership With HCLTech to Boost Manufacturing Excellence and Innovation15.12.2025 15:29:00 EET | Press release

HCLTech, a leading global technology company, and Aurobay Technologies, a division of Horse Powertrain and a global leader in hybrid and low-emission powertrain solutions, have expanded their digital transformation partnership to support Aurobay’s global growth strategy. The expanded partnership establishes HCLTech as Aurobay Technologies’ trusted partner for managing and optimizing SAP, Siemens Teamcenter PLM software and integration services in Sweden and China. This will unlock cost efficiency, operational resilience and digital innovation across Aurobay’s manufacturing and engineering functions by leveraging HCLTech’s flagship service transformation platform, AI Force. The engagement spans core business functions including SAP operations, engineering systems, integration services and mainframe environments, reinforcing Aurobay’s focus on scale, efficiency and seamless operations across global locations. “Horse Powertrain’s division Aurobay Technologies’ digital transformation conti

Applications Now Open for the 5th Cycle of the Mohammed bin Rashid Al Maktoum Global Water Award15.12.2025 15:28:00 EET | Press release

HE Saeed Mohammed Al Tayer, Chairman of the Board of Trustees of the UAE Water Aid Foundation (Suqia UAE), announced the opening of applications for the 5th cycle of the Mohammed bin Rashid Al Maktoum Global Water Award, offering USD 1 million in prizes. The award seeks to inspire innovative, clean energy–powered solutions for water production, distribution, storage, desalination and purification, supporting global sustainability efforts. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215897854/en/ HE Saeed Mohammed Al Tayer, Chairman of the Board of Trustees of the UAE Water Aid Foundation (Suqia UAE) - (Photo: AETOSWire) “Since its establishment, Suqia UAE, launched by His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai, has provided clean water to nearly 15 million people in 37 countries worldwide through sustainable development and humanitarian projects.

Novotech Issues White Paper to Help Sponsors Strengthen Early-Phase Oncology Strategy and Execution15.12.2025 15:05:00 EET | Press release

Novotech, a leading global full-service clinical research organization (CRO) and scientific advisory company, has released a new white paper, Early-Phase Oncology – Clinical Research Landscape and CRO Enablers (2025), offering in-depth analysis of the key drivers shaping early-phase oncology development. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215843975/en/ With approximately 60% of oncology agents progressing from Phase I to Phase II, but only 3–6% reaching regulatory approval, the paper outlines the factors influencing early-stage success, including trial design, patient selection, and regional development pathways. The paper highlights Australia’s continued position as a global first-in-human (FIH) and early-phase research hub. Its ethics-led review frameworks, which can support trial initiation within roughly 4–8 weeks, combined with established FIH centers, oncology networks, and cost efficiencies, position Au

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye